110 related articles for article (PubMed ID: 10223249)
1. Serum CA125 elevation and risk of clinical detection of cancer in asymptomatic postmenopausal women.
Jeyarajah AR; Ind TE; Skates S; Oram DH; Jacobs IJ
Cancer; 1999 May; 85(9):2068-72. PubMed ID: 10223249
[TBL] [Abstract][Full Text] [Related]
2. Increased mortality in postmenopausal women with serum CA125 elevation.
Jeyarajah AR; Ind TE; MacDonald N; Skates S; Oram DH; Jacobs IJ
Gynecol Oncol; 1999 May; 73(2):242-6. PubMed ID: 10329041
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation.
Menon U; Talaat A; Jeyarajah AR; Rosenthal AN; MacDonald ND; Skates SJ; Sibley K; Oram DH; Jacobs IJ
Br J Cancer; 1999 Jul; 80(10):1644-7. PubMed ID: 10408412
[TBL] [Abstract][Full Text] [Related]
4. A randomized study of screening for ovarian cancer: a multicenter study in Japan.
Kobayashi H; Yamada Y; Sado T; Sakata M; Yoshida S; Kawaguchi R; Kanayama S; Shigetomi H; Haruta S; Tsuji Y; Ueda S; Kitanaka T
Int J Gynecol Cancer; 2008; 18(3):414-20. PubMed ID: 17645503
[TBL] [Abstract][Full Text] [Related]
5. Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer.
Menon U; Skates SJ; Lewis S; Rosenthal AN; Rufford B; Sibley K; Macdonald N; Dawnay A; Jeyarajah A; Bast RC; Oram D; Jacobs IJ
J Clin Oncol; 2005 Nov; 23(31):7919-26. PubMed ID: 16258091
[TBL] [Abstract][Full Text] [Related]
6. Does serum CA125 have clinical value for follow-up monitoring of postoperative patients with epithelial ovarian cancer? Results of a 12-year study.
Guo N; Peng Z
J Ovarian Res; 2017 Mar; 10(1):14. PubMed ID: 28284216
[TBL] [Abstract][Full Text] [Related]
7. Pre- and postmenopausal high-risk women undergoing screening for ovarian cancer: anxiety, risk perceptions, and quality of life.
Hensley ML; Robson ME; Kauff ND; Korytowsky B; Castiel M; Ostroff J; Hurley K; Hann LE; Colon J; Spriggs D
Gynecol Oncol; 2003 Jun; 89(3):440-6. PubMed ID: 12798709
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing serum concentration of CA125 and CA15-3 in Iranian healthy postmenopausal women.
Dehaghani AS; Ghiam AF; Hosseini M; Mansouri S; Ghaderi A
Pathol Oncol Res; 2007; 13(4):360-4. PubMed ID: 18158573
[TBL] [Abstract][Full Text] [Related]
9. Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening.
Menon U; Talaat A; Rosenthal AN; Macdonald ND; Jeyerajah AR; Skates SJ; Sibley K; Oram DH; Jacobs IJ
BJOG; 2014 Dec; 121 Suppl 7():35-9. PubMed ID: 25488086
[TBL] [Abstract][Full Text] [Related]
10. CA125 reference values change in male and postmenopausal female subjects.
Cartei G; Cartei F; Bertin M; Padoan A; Zustovich F; Nicoletto MO; Plebani M
Clin Chem Lab Med; 2013 Feb; 51(2):413-9. PubMed ID: 23006901
[TBL] [Abstract][Full Text] [Related]
11. Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status.
Skates SJ; Mai P; Horick NK; Piedmonte M; Drescher CW; Isaacs C; Armstrong DK; Buys SS; Rodriguez GC; Horowitz IR; Berchuck A; Daly MB; Domchek S; Cohn DE; Van Le L; Schorge JO; Newland W; Davidson SA; Barnes M; Brewster W; Azodi M; Nerenstone S; Kauff ND; Fabian CJ; Sluss PM; Nayfield SG; Kasten CH; Finkelstein DM; Greene MH; Lu K
Cancer Prev Res (Phila); 2011 Sep; 4(9):1401-8. PubMed ID: 21893500
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing serum CA125II levels in healthy postmenopausal women.
Pauler DK; Menon U; McIntosh M; Symecko HL; Skates SJ; Jacobs IJ
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):489-93. PubMed ID: 11352859
[TBL] [Abstract][Full Text] [Related]
13. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
[TBL] [Abstract][Full Text] [Related]
14. Serum CA 125 combined with transvaginal ultrasonography for ovarian cancer screening.
Roupa Z; Faros E; Raftopoulos V; Tzavelas G; Kotrotsiou E; Sotiropoulou P; Karanikola E; Skifta E; Ardavanis A
In Vivo; 2004; 18(6):831-6. PubMed ID: 15646829
[TBL] [Abstract][Full Text] [Related]
15. Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening.
Menon U; Talaat A; Rosenthal AN; Macdonald ND; Jeyerajah AR; Skates SJ; Sibley K; Oram DH; Jacobs IJ
BJOG; 2000 Feb; 107(2):165-9. PubMed ID: 10688498
[TBL] [Abstract][Full Text] [Related]
16. Determination of a normal level of serum CA125 in postmenopausal women as a tool for preoperative evaluation and postoperative surveillance of endometrial carcinoma.
Kurihara T; Mizunuma H; Obara M; Andoh K; Ibuki Y; Nishimura T
Gynecol Oncol; 1998 Jun; 69(3):192-6. PubMed ID: 9648586
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of circulating CA125 prediction models in postmenopausal women.
Sasamoto N; Babic A; Rosner BA; Fortner RT; Vitonis AF; Yamamoto H; Fichorova RN; Titus LJ; Tjønneland A; Hansen L; Kvaskoff M; Fournier A; Mancini FR; Boeing H; Trichopoulou A; Peppa E; Karakatsani A; Palli D; Grioni S; Mattiello A; Tumino R; Fiano V; Onland-Moret NC; Weiderpass E; Gram IT; Quirós JR; Lujan-Barroso L; Sánchez MJ; Colorado-Yohar S; Barricarte A; Amiano P; Idahl A; Lundin E; Sartor H; Khaw KT; Key TJ; Muller D; Riboli E; Gunter M; Dossus L; Trabert B; Wentzensen N; Kaaks R; Cramer DW; Tworoger SS; Terry KL
J Ovarian Res; 2019 Nov; 12(1):116. PubMed ID: 31771659
[TBL] [Abstract][Full Text] [Related]
18. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.
Skates SJ; Menon U; MacDonald N; Rosenthal AN; Oram DH; Knapp RC; Jacobs IJ
J Clin Oncol; 2003 May; 21(10 Suppl):206s-210s. PubMed ID: 12743136
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of ovarian cancer among women with a CA125 level of 35 U/ml or less.
Kobayashi H; Yamada Y; Sado T; Sakata M; Yoshida S; Kawaguchi R; Kanayama S; Shigetomi H; Haruta S; Tsuji Y; Ueda S; Kitanaka T; Oi H
Gynecol Obstet Invest; 2008; 65(2):133-8. PubMed ID: 17957102
[TBL] [Abstract][Full Text] [Related]
20. Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women.
Cho HY; Park SH; Park YH; Kim HB; Kang JB; Hong SH; Kyung MS
J Korean Med Sci; 2015 Dec; 30(12):1777-83. PubMed ID: 26713052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
